FIBROCYSTIC BREAST DISEASE

This adverse event was reported 738 times

FIBROCYSTIC BREAST DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 7 0.0022
1 Provitamin D2 Compound [EPC] 47 0.0016
2 Guanylate Cyclase-C Agonist [EPC] 2 0.0010
3 Methylating Agent [EPC] 1 0.0010
4 Estrogen [EPC] 173 0.0009
5 Pyrethroid [EPC] 1 0.0006
6 Progesterone [EPC] 13 0.0005
7 Non-Standardized Plant Allergenic Extract [EPC] 9 0.0005
8 alpha-Hydroxy Acid [EPC] 1 0.0005
9 Standardized Insect Venom Allergenic Extract [EPC] 3 0.0004
See all drug classes enriched for association with FIBROCYSTIC BREAST DISEASE